Detail akcie Autonomix Rg online

Business Summary: Autonomix Medical, Inc. is a medical device company focused on advancing technologies to develop how diseases involving the nervous system are diagnosed and treated. The Company’s first-in-class platform system technology includes a catheter-based microchip sensing array that may have the ability to detect and differentiate neural signals with greater sensitivity. It is developing its technology for pancreatic cancer and pancreatitis, conditions that can cause debilitating pain and need an effective solution. Its technology constitutes a platform to address dozens of potential indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. Its development efforts are divided into two parts: diagnostic sensing and therapeutic radiofrequency ablation. The Company is developing Autonomix system, which is primarily catheter-based, meaning that its sensing equipment is delivered to its targeted location via a lumen within the body.
Financial Summary: BRIEF: For the six months ended 30 September 2025, Autonomix Medical Inc revenues was not reported. Net loss increased 96% to $10.8M. Higher net loss reflects Advanced Medical Equipment & Technology segment loss increase of 96% to $11M. Basic Earnings per Share excluding Extraordinary Items increased from -$5.32 to -$2.45.